US Stock MarketDetailed Quotes

POAI Predictive Oncology

Watchlist
  • 1.060
  • 0.0000.00%
Close Apr 28 16:00 ET
9.47MMarket Cap-0.46P/E (TTM)

Predictive Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
6.87%-10.97M
24.33%-2.06M
-10.75%-2.28M
9.97%-3.22M
0.34%-3.42M
4.74%-11.78M
15.80%-2.72M
23.99%-2.06M
-7.20%-3.57M
-10.80%-3.43M
Net income from continuing operations
9.63%-10.86M
29.79%-2.1M
19.10%-1.36M
18.92%-3.18M
-23.29%-4.22M
53.31%-12.02M
62.20%-2.99M
58.61%-1.68M
62.24%-3.92M
-1.52%-3.42M
Operating gains losses
136.05%4.17K
746.25%4.74K
-460.47%-19.41K
371.57%19.85K
-1,918.00%-1.01K
88.59%-11.55K
-116.74%-733
66.11%-3.46K
92.29%-7.31K
92.94%-50
Depreciation and amortization
-4.02%695.66K
10.76%573.64K
3.02%-204.71K
-8.87%164.17K
-31.65%162.57K
-44.80%724.81K
55.67%517.91K
-163.78%-211.09K
-44.72%180.14K
-26.50%237.85K
Other non cash items
-66.61%100.37K
-99.98%15
-99.94%63
34.47%99.56K
-96.40%734
-42.46%300.6K
-15.08%95.75K
-8.75%110.41K
-17.78%74.04K
-89.73%20.4K
Change In working capital
-17.20%-914.56K
-56.30%-538.51K
-527.35%-696.22K
-427.98%-320.36K
342.48%640.53K
-190.04%-780.36K
-149.47%-344.54K
-112.20%-110.98K
87.74%-60.68K
-8.04%-264.16K
-Change in receivables
-2,562.37%-467.93K
-231.93%-281.73K
-40.00%-132.85K
182.66%122.41K
-462.87%-175.75K
-17.38%19K
3,391.41%213.55K
-911.80%-94.89K
-107.31%-148.09K
-45.72%48.43K
-Change in inventory
245.27%95.08K
320.31%118.65K
203.88%50.26K
-843.58%-126.5K
4.89%52.66K
-52.89%-65.45K
-185.18%-53.86K
-153.23%-48.39K
29.20%-13.41K
173.83%50.2K
-Change in prepaid assets
607.40%208.78K
2.64%-257.95K
205.45%539.75K
-231.01%-181.8K
218.64%108.78K
-152.47%-41.15K
-323.86%-264.94K
49.88%176.71K
139.10%138.77K
-146.51%-91.68K
-Change in payables and accrued expense
-2,265.67%-326.11K
-0.83%266.38K
-1,504.73%-1.14M
-314.24%-110.25K
314.28%660.57K
-98.10%15.06K
-36.07%268.6K
-90.44%81.35K
-258.44%-26.61K
37.88%-308.28K
-Change in other current liabilities
3.21%-426.87K
2.17%-431.46K
---3.62K
--10.15K
---1.95K
-1,635.29%-441.02K
-7,943.48%-441.02K
--0
--0
--0
-Change in other working capital
100.93%2.49K
171.18%47.59K
96.92%-6.96K
-203.09%-34.38K
-110.15%-3.77K
-737.99%-266.8K
-162.66%-66.87K
-537.17%-225.76K
54.87%-11.34K
959.31%37.17K
Cash from discontinued investing activities
Operating cash flow
6.87%-10.97M
24.33%-2.06M
-10.75%-2.28M
9.97%-3.22M
0.34%-3.42M
4.74%-11.78M
15.80%-2.72M
23.99%-2.06M
-7.20%-3.57M
-10.80%-3.43M
Investing cash flow
Cash flow from continuing investing activities
80.00%-9.51K
0
0
97.50%-6.48K
93.50%-3.03K
90.00%-47.55K
124.37%15.5K
268.91%242.69K
-37.69%-259.1K
41.87%-46.64K
Net PPE purchase and sale
55.84%-9.51K
--0
--0
97.46%-6.48K
87.56%-3.03K
94.87%-21.53K
126.75%15.5K
289.10%242.69K
-35.70%-255.36K
46.32%-24.37K
Net intangibles purchase and sale
--0
--0
--0
--0
--0
53.40%-26.02K
100.02%1
--0
---3.74K
36.08%-22.27K
Cash from discontinued investing activities
Investing cash flow
80.00%-9.51K
--0
--0
97.50%-6.48K
93.50%-3.03K
90.00%-47.55K
124.37%15.5K
268.91%242.69K
-37.69%-259.1K
41.87%-46.64K
Financing cash flow
Cash flow from continuing financing activities
2,545.55%3.94M
-75.86%-195.78K
241.36%888.28K
3.36M
-112.37K
-97.78%148.9K
-371.18%-111.32K
6,560.30%260.22K
0
0
Net issuance payments of debt
-200.00%-150.41K
-78.28%-195.78K
-130.48%-79.32K
--237.06K
---112.37K
--150.41K
---109.81K
--260.22K
--0
--0
Net common stock issuance
328,831.74%4.96M
--0
--1.26M
----
----
-100.02%-1.51K
93.61%-1.51K
--0
----
----
Net other financing activities
---870.96K
--0
---297.11K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
2,545.55%3.94M
-75.86%-195.78K
241.36%888.28K
--3.36M
---112.37K
-97.78%148.9K
-371.18%-111.32K
6,560.30%260.22K
--0
--0
Net cash flow
Beginning cash position
-60.45%8.73M
-74.16%3.08M
-63.89%5.33M
-72.05%5.2M
-60.45%8.73M
-21.74%22.07M
-53.08%11.92M
-47.74%14.76M
-25.95%18.6M
-21.74%22.07M
Current changes in cash
40.09%-7.99M
26.43%-2.34M
20.92%-2.25M
103.51%134.54K
-1.64%-3.53M
-117.63%-13.34M
4.09%-3.19M
0.25%-2.85M
-222.32%-3.83M
-12.55%-3.47M
End cash Position
-91.58%734.67K
-91.58%734.67K
-74.16%3.08M
-63.89%5.33M
-72.05%5.2M
-60.45%8.73M
-60.45%8.73M
-53.08%11.92M
-47.74%14.76M
-25.95%18.6M
Free cash flow
7.16%-10.98M
23.90%-2.06M
-25.55%-2.28M
15.88%-3.22M
1.59%-3.42M
7.90%-11.83M
17.90%-2.71M
36.33%-1.82M
-8.83%-3.83M
-9.47%-3.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 6.87%-10.97M24.33%-2.06M-10.75%-2.28M9.97%-3.22M0.34%-3.42M4.74%-11.78M15.80%-2.72M23.99%-2.06M-7.20%-3.57M-10.80%-3.43M
Net income from continuing operations 9.63%-10.86M29.79%-2.1M19.10%-1.36M18.92%-3.18M-23.29%-4.22M53.31%-12.02M62.20%-2.99M58.61%-1.68M62.24%-3.92M-1.52%-3.42M
Operating gains losses 136.05%4.17K746.25%4.74K-460.47%-19.41K371.57%19.85K-1,918.00%-1.01K88.59%-11.55K-116.74%-73366.11%-3.46K92.29%-7.31K92.94%-50
Depreciation and amortization -4.02%695.66K10.76%573.64K3.02%-204.71K-8.87%164.17K-31.65%162.57K-44.80%724.81K55.67%517.91K-163.78%-211.09K-44.72%180.14K-26.50%237.85K
Other non cash items -66.61%100.37K-99.98%15-99.94%6334.47%99.56K-96.40%734-42.46%300.6K-15.08%95.75K-8.75%110.41K-17.78%74.04K-89.73%20.4K
Change In working capital -17.20%-914.56K-56.30%-538.51K-527.35%-696.22K-427.98%-320.36K342.48%640.53K-190.04%-780.36K-149.47%-344.54K-112.20%-110.98K87.74%-60.68K-8.04%-264.16K
-Change in receivables -2,562.37%-467.93K-231.93%-281.73K-40.00%-132.85K182.66%122.41K-462.87%-175.75K-17.38%19K3,391.41%213.55K-911.80%-94.89K-107.31%-148.09K-45.72%48.43K
-Change in inventory 245.27%95.08K320.31%118.65K203.88%50.26K-843.58%-126.5K4.89%52.66K-52.89%-65.45K-185.18%-53.86K-153.23%-48.39K29.20%-13.41K173.83%50.2K
-Change in prepaid assets 607.40%208.78K2.64%-257.95K205.45%539.75K-231.01%-181.8K218.64%108.78K-152.47%-41.15K-323.86%-264.94K49.88%176.71K139.10%138.77K-146.51%-91.68K
-Change in payables and accrued expense -2,265.67%-326.11K-0.83%266.38K-1,504.73%-1.14M-314.24%-110.25K314.28%660.57K-98.10%15.06K-36.07%268.6K-90.44%81.35K-258.44%-26.61K37.88%-308.28K
-Change in other current liabilities 3.21%-426.87K2.17%-431.46K---3.62K--10.15K---1.95K-1,635.29%-441.02K-7,943.48%-441.02K--0--0--0
-Change in other working capital 100.93%2.49K171.18%47.59K96.92%-6.96K-203.09%-34.38K-110.15%-3.77K-737.99%-266.8K-162.66%-66.87K-537.17%-225.76K54.87%-11.34K959.31%37.17K
Cash from discontinued investing activities
Operating cash flow 6.87%-10.97M24.33%-2.06M-10.75%-2.28M9.97%-3.22M0.34%-3.42M4.74%-11.78M15.80%-2.72M23.99%-2.06M-7.20%-3.57M-10.80%-3.43M
Investing cash flow
Cash flow from continuing investing activities 80.00%-9.51K0097.50%-6.48K93.50%-3.03K90.00%-47.55K124.37%15.5K268.91%242.69K-37.69%-259.1K41.87%-46.64K
Net PPE purchase and sale 55.84%-9.51K--0--097.46%-6.48K87.56%-3.03K94.87%-21.53K126.75%15.5K289.10%242.69K-35.70%-255.36K46.32%-24.37K
Net intangibles purchase and sale --0--0--0--0--053.40%-26.02K100.02%1--0---3.74K36.08%-22.27K
Cash from discontinued investing activities
Investing cash flow 80.00%-9.51K--0--097.50%-6.48K93.50%-3.03K90.00%-47.55K124.37%15.5K268.91%242.69K-37.69%-259.1K41.87%-46.64K
Financing cash flow
Cash flow from continuing financing activities 2,545.55%3.94M-75.86%-195.78K241.36%888.28K3.36M-112.37K-97.78%148.9K-371.18%-111.32K6,560.30%260.22K00
Net issuance payments of debt -200.00%-150.41K-78.28%-195.78K-130.48%-79.32K--237.06K---112.37K--150.41K---109.81K--260.22K--0--0
Net common stock issuance 328,831.74%4.96M--0--1.26M---------100.02%-1.51K93.61%-1.51K--0--------
Net other financing activities ---870.96K--0---297.11K----------------------------
Cash from discontinued financing activities
Financing cash flow 2,545.55%3.94M-75.86%-195.78K241.36%888.28K--3.36M---112.37K-97.78%148.9K-371.18%-111.32K6,560.30%260.22K--0--0
Net cash flow
Beginning cash position -60.45%8.73M-74.16%3.08M-63.89%5.33M-72.05%5.2M-60.45%8.73M-21.74%22.07M-53.08%11.92M-47.74%14.76M-25.95%18.6M-21.74%22.07M
Current changes in cash 40.09%-7.99M26.43%-2.34M20.92%-2.25M103.51%134.54K-1.64%-3.53M-117.63%-13.34M4.09%-3.19M0.25%-2.85M-222.32%-3.83M-12.55%-3.47M
End cash Position -91.58%734.67K-91.58%734.67K-74.16%3.08M-63.89%5.33M-72.05%5.2M-60.45%8.73M-60.45%8.73M-53.08%11.92M-47.74%14.76M-25.95%18.6M
Free cash flow 7.16%-10.98M23.90%-2.06M-25.55%-2.28M15.88%-3.22M1.59%-3.42M7.90%-11.83M17.90%-2.71M36.33%-1.82M-8.83%-3.83M-9.47%-3.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.200
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.690
New Fortress Energy
NFE
5.760
4
Hutchmed (China)
HCM
15.080
5
Lantheus
LNTH
102.700
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.